2Morrow Awarded on TIME’s List of the World’s Top HealthTech Companies 2026

2Morrow has been named one of TIME and Statista’s World’s Top HealthTech Companies of 2026, earning recognition in the Prevention category. Out of thousands of healthtech companies reviewed worldwide, only 500 were named to the list.

KIRKLAND, WA, September 17, 2026 — 2Morrow has been included in the World’s Top HealthTech Companies 2026. This prestigious award is presented by TIME and Statista Inc., the world-leading statistics portal and industry ranking provider. The award list was announced on September 17th, 2026, and can be viewed on TIME.com.

The World’s Top HealthTech Companies 2026 ranking recognizes leading innovators advancing healthcare globally through technology. Companies were evaluated using three primary data sources: Financial Performance Metrics, Reputation Analysis, and Online Engagement. Out of thousands of HealthTech companies reviewed, the top 500 were recognized for their outstanding performance across these critical areas. Based on the results of the study, 2Morrow is ecstatic to be recognized on TIME’s list of the World’s Top HealthTech Companies 2026.

Statista publishes hundreds of worldwide industry rankings and company listings with high-profile media partners. This research and analysis service is based on the success of statista.com, the leading data and business intelligence portal that provides statistics, relevant business data, and various market and consumer studies and surveys.

“Health technology is most valuable when it helps people turn their goals and values into action in everyday life,” said Jo Masterson, CEO of 2Morrow. “I’m proud of the 2Morrow team for making behavioral science practical and accessible, and grateful to the partners and participants whose experiences continue to shape our work.”

###

About 2Morrow

2Morrow is a Kirkland, Washington-based digital health company delivering evidence-based behavioral health and wellness programs through employers, health plans, and states. Since 2011, 2Morrow’s programs have reached more than one million people seeking support with tobacco and nicotine cessation, stress management, and other health behavior changes. The company also offers programs addressing mood, weight, sleep, and chronic pain. Its evidence base includes a Phase III randomized clinical trial in smoking cessation and NIH-funded chronic pain research. Learn more at 2morrowinc.com.

Media Contact:

Deanna Waters

Vice President of Participant Success

2Morrow Inc

dwaters@2morrowinc.com

🌐 www.2morrowinc.com